Hemogenyx Pharmaceuticals Competitors and Similar CompaniesClear all

Hemogenyx Pharmaceuticals's competitors and similar companies include Lepu Biopharma, LTS Lohmann Therapie-Systeme, Teva Pharmaceuticals and Umecrine Cognition.
Hemogenyx Pharmaceuticals
Hemogenyx Pharmaceuticals
Hemogenyx Pharmaceuticals, formerly Silver Falcon, is a pre-clinical stage biopharmaceutical company.
Lepu Biopharma
Lepu Biopharma
Lepu Biopharma is a biopharmaceutical company that focuses on oncology therapeutics.
LTS Lohmann Therapie-Systeme
LTS Lohmann Therapie-Systeme
LTS Lohmann Therapie-Systeme develops and manufactures transdermal drug delivery systems for pharmaceutical active substances.
Teva Pharmaceuticals
Teva Pharmaceuticals
Teva Pharmaceuticals is a global pharmaceutical company.
Umecrine Cognition
Umecrine Cognition
Umecrine Cognition is a company developing pharmaceuticals against neurological disorders in the central nervous system.
Founding Date
Founding Date
2013
Founding Date
2018
Founding Date
1984
Founding Date
1901
Founding Date
2006
Type
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Type
Subsidiary
Tags
Locations
Locations
London, GB HQ
Locations
HK HQ
Locations
Andernach, DE HQ
Shanghai, CN
West Caldwell, US
Locations
Petah Tikva, IL HQ
Villa Adelina, AR
Macquarie Park, AU
Minsk, BY
Antwerpen, BE
Sao Paulo, BR
Dupnica, BG
see more
Locations
Solna, SE HQ
Employees
Employees
14
Employees
436
Employees
2881% increase
Employees
35,0013% increase
Employees
6
Valuation ($)
Valuation ($)
25.8 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
18.9 b
Valuation ($)
N/A
Twitter followers
Twitter followers
7
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
3.6 k
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
¥15.6m (FY, 2022)
Revenue (est.)
N/A
Revenue (est.)
$15.8b (FY, 2023)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
¥2m (FY, 2022)
Cost of goods
N/A
Cost of goods
$8.2b (FY, 2023)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
¥24.7m (FY, 2022)
Gross profit
N/A
Gross profit
$7.6b (FY, 2023)
Gross profit
N/A
Net income
Net income
(£4m) (FY, 2022)
Net income
(¥699.4m) (FY, 2022)
Net income
N/A
Net income
($615m) (FY, 2023)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 358m
Total funding raised
$ 2.5m
For sources of this data, please see the company profile

View Company Profiles

Lepu Biopharma
HQ
HK
Employees
436

Lepu Biopharma is a biopharmaceutical company that focuses on oncology therapeutics.

View company
LTS Lohmann Therapie-Systeme
HQ
Andernach, DE

LTS Lohmann Therapie-Systeme develops and manufactures transdermal drug delivery systems for pharmaceutical active substances.

View company
Teva Pharmaceuticals
HQ
Petah Tikva, IL
Employees
35,001↑ 3% increase

Teva Pharmaceuticals is a global pharmaceutical company.

View company
Umecrine Cognition
HQ
Solna, SE

Umecrine Cognition is a company developing pharmaceuticals against neurological disorders in the central nervous system.

View company